Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations
Jennifer S. Gewandter(Heinrich Heine University Düsseldorf), Richard E. White(Endo Pharmaceuticals (United States)), Ian Gilron(Apple (Israel)), Stephen Senn(Laboratoire National de Santé), Michael S. Leong(Stanford University), Karin L. Petersen(Northwestern University), Charles Taylor(RED Consulting (Norway)), Christine Rauschkolb(Johnson & Johnson (United States)), Marc R. Gastonguay(Metrum Research Group (United States)), Richard L. Leff, Rolf‐Detlef Treede(Heidelberg University), Ralf Baron(Apple (Israel)), Cyrus R. Mehta(Cytel (United States)), David Hewitt(Glasgow Royal Infirmary), Paul J. Desjardins(Rutgers, The State University of New Jersey), Jonathan Stewart(GlaxoSmithKline (Netherlands)), Robert D. Kerns(VA Connecticut Healthcare System), Robert H. Dworkin(University of Rochester), Ilona Steigerwald(Grünenthal Group (Germany)), Jeffrey Tobias(Jazz Pharmaceuticals (United States)), Eija Kalso(University of Helsinki), Joseph Stauffer, Raymond A. Dionne(East Carolina University), Andrew S.C. Rice(Imperial College London), John T. Farrar(University of Pennsylvania), Srinivasa N. Raja(Johns Hopkins Medicine), Mark S. Wallace, Michael P. McDermott(University of Rochester), Smriti Iyengar(Eli Lilly (United States)), Dennis C. Turk(University of Washington), Penney Cowan(American Chronic Pain Association), Michael C. Rowbotham(Apple (Israel)), Rozalina Dimitrova(Allergan (United States)), Nathaniel P. Katz(Apple (Israel)), Bernard Ravina(Voyager Therapeutics (United States)), Cristina Sampaio(CHDI Foundation)
Cited by 110
Related Papers
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
|Psychological Bulletin|2007|3.3k
A classification of chronic pain for ICD-11
|Pain|2015|2.8k
Neuropathic pain
|Nature Reviews Disease Primers|2017|2k